Recording from Wednesday, April 22, 2020

The presenters provided
> A high-level overview of continuous manufacturing including efforts and status for ICH > Q13 Continuous Manufacturing of Drug Substances and Drug Products Guideline.
> Identify potential problems with excipients used in continuous manufacturing
> Discuss current and future continuous manufacturing equipment needs
> Explore future needs for excipients designed for purpose in continuous manufacturing; and
> Present a regulatory perspective on use of continuous manufacturing for pharmaceutical products.

Attendees were able to
> Recognize similarities and differences between batch processing and continuous processing needs
> Ascertain basic material and process considerations for continuous manufacturing
> Anticipate future continuous manufacturing equipment and/or material needs
> Understand the current continuous manufacturing regulatory landscape